Evaluation of the Healing of the Pilonidal Cyst After 1940 nm Laser Treatment

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorGCS Ramsay Santé pour l'Enseignement et la Recherche

About this trial

The aim of this study is to evaluate the extent to which the reduction of energy absorption that laser 1940 nm allows could improve the outcomes and postoperative results of the treatment of pilonidal cysts.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients who did not object to the collection of their data

Patients who underwent surgery for a pilonidal cyst using 1940 nm laser treatment

Disqualifiers

Patients with a history of pilonidal cyst surgery

Patients who underwent emergency surgery for an abscess

Patients already included in another therapeutic study protocol

Trial population

patients treated with laser 1940 nm for a pilonidal cyst.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • pilonidal cyst laser surgery

    Procedure/Surgery

    pilonidal cyst using 1940 nm laser treatment

Treatment groups

30 Participants
are divided into 1 treatment group
Group A: LASER 19401 intervention

Trial outcomes

Primary outcomes

1

HEALING

The main objective is to evaluate the healing rate of the pilonidal sinus one month after treatment with Er-YAG laser 1940 nm. Wound healing at one month, defined by the absence of a dressing, is the main evaluation criterion.

Time frame
1 Month

Secondary outcomes

1

Recidivism

Recidivism is defined by: - The presence of persistent troubling symptoms 6 months after the surgery: suppuration, recurrent wound dehiscence, lack of healing despite care deemed optimal by the expert, reactivation/recurrence of abscesses. - The presence of a characteristic image on MRI if this examination has been carried out: subcutaneous collection, in hyper T2.

Time frame
6 Month

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.